Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma.

Jo, Masayasu; Yasui, Kohichiroh; Kirishima, Toshihiko; Shima, Toshihide; Niimi, Toshihisa; Katayama, Takayuki; Mori, Takahiro; Funaki, Jun; Sumida, Yoshio; Fujii, Hideki; Takami, Shiro; Kimura, Hiroyuki; Mitsumoto, Yasuhide; Minami, Masahito; Yamaguchi, Kanji; Yoshinami, Naomi; Mizuno, Masayuki; Sendo, Rei; Tanaka, Saiyu; Shintani, Hiroyuki; Kagawa, Keizo; Okanoue, Takeshi; Itoh, Yoshito

Jo, Masayasu; Yasui, Kohichiroh; Kirishima, Toshihiko; Shima, Toshihide; Niimi, Toshihisa; Katayama, Takayuki; Mori, Takahiro; Funaki, Jun; Sumida, Yoshio; Fujii, Hideki; Takami, Shiro; Kimura, Hiroyuki; Mitsumoto, Yasuhide; Minami, Masahito; Yamaguchi, Kanji; Yoshinami, Naomi; Mizuno, Masayuki; Sendo, Rei; Tanaka, Saiyu; Shintani, Hiroyuki; Kagawa, Keizo; Okanoue, Takeshi; Itoh, Yoshito.

Afiliación

Jo M; Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Molecular Gastroenterology and Hepatology, North Medical Center Kyoto Prefectural University of Medicine, Yosano, Japan.

Hepatol Res ; 44(13): 1329-38, 2014 Dec.

Article en En | MEDLINE | ID: mdl-24528772

Palabras clave

elderly patient; hepatocellular carcinoma; sorafenib

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Hepatol Res Año: 2014 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google